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1. Introduction 
Anorexia Nervosa is a serious, potentially life-threatening illness characterized by severe 
malnutrition, with abnormally low body weight (BMI <17.5 kg/m2 or body weight at least 
15% below the expected value),  an intense fear of weight gain, and an undue emphasis on 
weight and shape in self-evaluation. Amenorrhea (i.e. loss of three consecutive menstrual 
cycles) is currently required for the diagnosis, but often is hidden by contraceptive drugs. 
Anorexia nervosa can cause significant clinical complications in every organ system, 
particularly relevant in adolescents in the growing and developing body with slowing in 
linear growth, impaired bone mineral accretion,  structural and functional damage of the 
brain. Most of these complications are reversible if there is a timely restoration of body 
weight, since weight restoration is associated with concomitant decrease in anorectic 
symptoms and an improvement in physical and cognitive function (American Academy of 
Pediatrics. Committee on Adolescence. Identifying and treating eating disorders. Pediatrics, 
2003; American Dietetic Association, Nutrition intervention in the treatment of eating 
disorders, 2011; American Psychiatric Association. Work Group on Eating Disorders. Practice 
Guideline for the treatment of Patients with Eating Disorders. 2006; Beumont, 2004; Eating 
Disorders. Core Interventions in the treatment and management of anorexia nervosa, bulimia 
nervosa and related eating disorders. National Institute for Clinical Excellence, 2004). 
Weight restoration is also a prerequisite for psychotropic interventions and effective use of 
psychotherapeutic therapy (Eating Disorders. Core Interventions in the treatment and 
management of anorexia nervosa, bulimia nervosa and related eating disorders. National 
Institute for Clinical Excellence, 2004; Stanga et al., 2007). 
Moreover, we also must consider that anorexia nervosa patients display the highest death 
rate of all mental illnesses and a relevant part of mortality has to be attributed to 
undernutrition. 
If undernutrition is severe, patients are at high risk, and medical complications affect 
virtually every organ system. Severely undernourished patients, if not appropriately treated 
with a specialized in-patient care program, may present cardiovascular, metabolic 
complications, and abnormalities in brain functions, and it is not infrequent for these 
complications to require treatment in intensive care units, thus extending hospitalisation 
time and consequently increasing costs (Golden & Meyer, 2004; Gentile et al., 2008).   
www.intechopen.com
 
Relevant Topics in Eating Disorders 
 
384 
Severe and protracted undernutrition nearly always leads to marked changes in body spaces 
(e.g. intra-extracellular water), in body masses (e.g. potassium, phosphate, magnesium 
overall and compartmental stores), in equilibrium relationships between bodily spaces, 
concentrations and in feedback mechanisms which are set at new-pathological levels of 
functioning. These changes set the body at risk of refeeding syndrome, i.e. the disturbances 
caused by a too rapid / or unbalanced refeeding which the deranged bodily system just 
referred  to be unable to support (Mehanna et al., 2008).   
Several guidelines, papers and reviews provide guidance for medical and nursing staff 
managing patients with severe undernutrition and/or at risk of refeeding syndrome. There 
are also many reports of medical complications in refeeding anorexia nervosa patients 
(Stanga et al., 2008; Marinella et al., 2005; Hearing, 2004; Birmingham, 2008).     
So, caring for severely starved patients with anorexia nervosa and re-starting nutrition 
commands close monitoring seeking for early signs or symptoms of refeeding and 
specialized care operating, within a timely plan, both at a physical (first) and emotional level 
(successively),  the final goal being to restore a healthy, self managing  person to her/his 
family and social environment (Gentile et al., 2010).   
Until now there has been no category A evidence for treatment of anorexia nervosa, but 
international guidelines and society position papers agree in defining the best treatment as a 
multidisciplinary, comprehensive and rigorous process conducted by a team of medical, 
nutritional, mental health and nursing professionals, experienced in the evolution and 
treatment of eating disorders (American Academy of Pediatrics. Committee on Adolescence. 
Identifying and treating eating disorders. Pediatrics, 2003; Eating Disorders. Core 
Interventions in the treatment and management of anorexia nervosa, bulimia nervosa and 
related eating disorders. National Institute for Clinical Excellence, 2004).  
Usually Centres that treat inpatient anorexia nervosa who have moderate or severe degrees 
of undernutrition use a combination of behavioural techniques, cognitive restructuring and 
a progressive structured program of oral caloric intake to achieve the goal of weight 
restoration. In the more complicated cases i.e. patients with extreme undernutrition and life  
threatening weight loss or patients unwilling to take dietary treatment or refusing oral 
intake, artificial nutrition has been utilized (Table 1). 
 
Patient with severe malnutrition (BMI ≤ 13 Kg/m2) disposed to intake less than 100% of 
the caloric needs or patients with body weight not increasing 
Patient with BMI between 13 -15 Kg/m2 showing a reduction of measured resting 
metabolic rate more than 30% of exstimated basal metabolic rate according to Harris 
Benedict formula. 
Patient unwilling to take dietary treatment or refusing any oral intake but accepting only 
Artificial Nutrition.
Table 1. Criteria for life-saving intervention with artificial nutrition in anorexia nervosa 
patients 
Although  it has always been  stressed  how crucial nutritional  rehabilitation is in these 
patients, where only few studies are reporting the use of artificial nutrition in anorexia 
nervosa patients. Enteral nutrition and parenteral nutrition are both used in nutritional 
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rehabilitation of severe anorexia nervosa patients (Paccagnella et al., 2006; Robb et al., 2002; 
Tonoike et al., 2004; Zuercher et al., 2003; Gentile et al., 2008; Gentile et al., 2010).    
Given the recognised difficulties in conducting randomized clinical trials in patients with 
anorexia nervosa, evidence-based guidelines for enteral and parenteral nutrition are lacking. 
If we apply the international guidelines for  the use of artificial nutrition (“if guts work you 
must use it”) also in those anorexia nervosa patients who require life-saving intervention 
with artificial nutrition, we must choose enteral nutrition while parenteral nutrition should 
be considered only for very rare patients with impaired intestinal function  (Lochsa  et al., 
2006; Bankhead et al., 2009) (Table 2). 
 
Enteral tube feeding should be considered in people who are malnourished and have 
inadequate or unsafe oral intake and a functional accessible gastrointestinal tract.  
Reducing contamination 
Use of sterile, non-manipulated closed systems for enteral tube feeding administration 
and good hygiene, along with routine microbial surveillance reduce contamination 
associated with preparation. The use of closed system enteral administration set has been 
demonstrated to be safe for 24 hours. 
Enteral formula stability 
The stability of each component of an enteral tube feeding formula is important to 
maintaining the product’s integrity and the patient’s nutrition status. 
Selection of Enteral Access Devices 
In general  gastric access relies on a functional stomach free of delayed gastric emptying 
obstruction or fistula. Small bowel feedings are most appropriate for patients with gastric 
outlet obstruction gastroparesis, pancreatitis and in those with known reflux and 
aspiration of gastric contents. Enteral access devices inserted via the nasal routes are 
usually placed for short-term use in the hospitalized patient. 
Table 2. Indication for enteral tube feeding and practice recommendation 
Enteral feeding must be closely monitored and regulated via a electronically operated 
pump. Nasogastric feeding is the preferred procedure in many eating disorders units, 
because it is a safe and simple non surgical procedure that can be performed also by nursing 
staff. Compared with other methods of refeeding nasogastric feeding has a lower risk of 
complications and is cost-efficient. 
The aim of this retrospective cohort study is to describe our experience with the use of 
enteral tube feeding for gradual correction of severe undernutrition in anorexia nervosa 
patients according to main international guidelines for the use of artificial nutrition and  to 
available studies and clinical experience that support the effectiveness of enteral nutrition in 
weight restoration. 
2. Patients and methods 
2.1 Patients 
We treated 122 (118 females, 4 males) inpatients, referred to the Eating Disorders Unit of 
Niguarda Hospital and affected by severe undernutrition  due to anorexia nervosa 
(according to the Diagnostic and Statistical Manual of Mental Disorders, 2000),  treated with 
nasogastric enteral nutrition.  The observation period was from May 1999 to January 2011. 
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2.2.1 Anthropometry and resting metabolic rate 
Body weight was recorded to the nearest 100 g, using a standard physician's weight scale 
with patient wearing only underwear (without shoes). Height was determined to the nearest 
0.5 cm on a standard stadiometer.  
Resting gas exchange was measured by open circuit, indirect calorimetry (Sensor Medics) 
for 30 minutes. Before each measurement, the system was re-calibrated using a reference gas 
mixture of 95% O2 and 5% CO2. 
3. Treatment 
Our multidisciplinary treatment consist in: 
a. Behavioural and psychological therapy for patient and their parents. 
b. Nutritional rehabilitation to restore weight correcting biological and psychological 
consequences of undernutrition. 
Usually caloric intake levels were established beginning with indirect calorimetric 
measurements because resting energy expenditure is the main component of daily 
expenditure particularly in severely malnourished patients. 
For severely malnourished patients, our nutritional rehabilitation program includes 
temporary supplementation with liquid food supplements, or -  in life-threatening situations 
- temporary nasogastric feeding.  
In our experience, enteral nutrition is necessary only in a minority of inpatients with a 
relevant degree of malnutrition and for a limited period of time. Enteral nutrition must 
always be integrated in a multidisciplinary approach, and managed by an expert team. In 
order to reduce gastric discomfort, it is usually administered via a nasogastric feeding tube 
and consists of a polymeric diet free of lactose and gluten, with a  high degree of calories,  a 
high nitrogen, complete fluid formula. The flow rate is maintained constant with a pump, 
during all infusion time (Table 3). 
Enteral nutrition was used until the patients were no longer at life-risk and they started to 
collaborate with the treatment, increasing oral food amounts to a significant amount. 
Dietary management was devised to achieve also behavioural modifications, patients were 
encouraged – not forced to eat enough to restore their weight. 
Vitamin supplementation started just before feeding and continued during refeeding days. 
Electrolyte levels were measured and if necessary supplemented. Phosphate supplements 
were administered unless blood levels were above normal values. 
3.1 Data analysis 
Data were analyzed with the SAS PACKAGE (Release 8.2 by SAS Institute Inc. Cary NC 
USA, 2002). The results are reported as means ± Standard Deviations or frequencies and 
percentages. Changes in body weight and body mass indexes at admission and those after 
enteral nutrition treatment were tested with the sign test for paired data. The hypothesis of 
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Calorie dense         1,7 - 2 Kcal/ml
Delivery site 
Route                      Access 
Gastric                    Nasogastric
Method of Administration
Method 
Pump - assisted                    Rate 
                                                Initial                                20 - 30 ml/h 
                                               Advance to goal of          40 - 50 ml/h or more if tolerated, start 
                                                                                           with  a 24-hour per day  and proceed 
                                                                                           with a drop infusion for 18-12-8 hours 
                                                                                           per day if tolerated. 
Other indications
Flush the feeding tube with indicated amount of water every 6 - 8 hours 
No interruption of oral feeding if it is accepted 
Monitoring 
Check gastric residual volume according individual necessity 
Observe for abdominal distension, nasogastric tube site and assessment at least twice a day 
Weight daily 
Table 3. Specific enteral nutrition protocol for Anorexia Nervosa patient 
no difference between the body weight and the body mass index at admission and after 
enteral nutrition treatment was rejected by a p < 0.0001 for both variables. 
4. Results 
One hundred twenty-two patients were eligible for the study. Mean BMI was 13.1 ± 1.6 
kg/m2 and the mean age was 23.7 ± 9.7 years. A summary of patients’ anamnestic, 
demographic and clinical characteristics are reported in Table 4. 
 Mean S.D. Range 
Number of patients 122   
Age at reported onset/diagnosis of Anorexia Nervosa 18.8 6.7 ( 10.0 – 42.0) 
Duration of disease (months) 54.4 64.1 ( 2 - 356) 
Age at beginning of enteral nutrition treatment (years) 23.7 9.7 (10 - 64) 
Body Mass index (kg/m2) at beginning of enteral nutrition 13.1 1.6 (9.7 – 18.6) 
Body weight (kg) at beginning of enteral nutrition 34.4 6.2 (19.5 – 63.8) 
Height (cm) 162 0.1 (137 - 185) 
Estimated resting metabolic rate (Kcal/24 h) 1166 120.5 (826 - 1724) 
Measured resting metabolic rate (Kcal/24h) 860 160.5 (580 - 1356) 
% difference versus estimated basal metabolic rate 
according to HB formula 
-25.7 12.3 (-47 - 9) 
a Values are means ± SDs, range in parenthesis 
Table 4. Anamnestic, demographic and clinical data of Anorexia Nervosa patients treated by 
Enteral Nutrition a 
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We observed a clinically significant reduction in measurement resting metabolic rate (- 25.7 
± 12.3%) respect to estimated basal metabolic rate according to Harris Benedict formula. 
Table 5 presents the results of 122 anorexia nervosa patients treated with enteral nutrition. 
These patients continued to be treated by enteral nutrition till the achievement of BMI 16.4 ± 
1.35 kg/m2  (t=1). Mean body weight increased from 34.4 ± 6.2 kg to 43 ± 0.5 kg after 96 ± 91 
days of enteral nutrition treatment with a mean enteral caloric supply of 1378 ± 261 Kcal; 
oral diet was never stopped. Patients and dieticians, together, selected a menu each day. 
Dieticians helped patients choose their own meals and provided a personalized, structured 
meal plan, which ensured nutritional adequacy and the inclusion of all major food groups.  
Nasogastric tube feeding was continuously delivered over 24 h daily for the first 20-30 days, 
using feed pumps also to reduce gastric discomfort; as clinical conditions improved we 
proceeded with a drop infusion of 18-12-8 hours per day. We used a caloric dense completely 
fluid-formula diet, high nitrogen with protein intake of 1.63 ± 0.3 g/kg/body weight.  
 
 T = 0 T =1 T =2 
N 122   
Body weight (kg) 34.4 ± 6.2 43.0 ± 5.5 a 47.4 ± 7.4 
Body mass index (kg/m2) 13.1 ± 1.6 16.4 ± 1.35 a 18.0 ± 2.5 
Duration Enteral Therapy (days)  96 ± 91  
Enteral feeding regimen Kcal/day  1378 ± 261  
Amount of  fluid enteral diet ml/day  707 ± 181  
Amount of fluid enteral diet ml/hour  29 ± 8  
Caloric dense amount Kcal/ml  1.9 ± 0.2  
Protein g/day  56.1 ± 13.9  
Protein g/kg Body weight  1.63 ± 0.3  
Δ weight (kg)  8.7 ± 4.4 12.8 ± 7 
Δ weight /month (Kg)  3.6 ± 2.0 0.7 ± 1.0 
T=0 onset of Enteral Nutrition Treatment, T=1 at end Enteral Nutrition Treatment, 
T=2 at the last out patient check after 599 ± 670 days 
a  significantly different from t=0 
Table 5. Clinical variables of 122 anorexia nervosa inpatient treated by enteral nutrition 
We started slowly and we gradually increased the caloric intake during the first week to 
avoid refeeding  syndrome. 
5. Conclusion 
Enteral nutrition was well tolerated and in those inpatients with severe, life-threatening  
undernutrition did not present any major complications, neither gastrointestinal 
complications such as diarrhea, vomiting, nor metabolic alterations such as hypoglycemia or 
hypophosphoremia nor hepatic malfunction. 
If enteral feeding is integrated in a psychotherapeutic, empathic medical, nursing and 
dietitian approach the patients initially oppose it, but then, their compliance and co-
operation is generally reasonable. 
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We choose to use enteral nutrition because we considered parenteral nutrition is more 
dangerous for developing a refeeding syndrome, and we agreed that parenteral nutrition 
should not be necessary for nutritional rehabilitation in Anorexia nervosa patients unless 
there is significant gastrointestinal dysfunction. In the group of 122 patients we never used 
it. In more severe patients we used infusion of 5-10% glucose fluid delivered during 24 
hours a day until the metabolic alterations improved. The caloric intake was very gradually 
advanced in the first weeks to prevent the refeeding syndrome in those patients who are 
considered to be in high risk of refeeding syndrome. Prevention of refeeding syndrome is of 
crucial importance. The refeeding syndrome, a potentially lethal complication of refeeding 
the malnourished patient, can result in potential metabolic and pathophysiological 
complications, which can affect the cardiac, respiratory hematological, hepatic and 
neuromuscular systems leading to clinical complications and even death.     
We choose to start with a 24 hour continuous flow supplement to reduce gastric discomfort, 
diarrhea and metabolic alterations, and only when the undernutrition was partially 
corrected, we gradually reduced the infusion time. 
Our results seem to provide strong support for using a highly structured program for 
treating patients with severe anorexia nervosa; highly specialized eating disorder inpatient 
treatment is more effective and acceptable than standard psychiatric care, also the use of 
artificial nutrition and dietary management alone are both unacceptable as a primary 
interventions and ineffective as a form of relapse prevention, the overall conclusion is that 
therapies should have a full cooperation of the multidisciplinary medical and psychological 
teams specialized in eating disorders treatment. 
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